|
1
|
Mease P: Fibromyalgia syndrome: Review of
clinical presentation, pathogenesis, outcome measures, and
treatment. J Rheumatol. 75:6–21. 2005.
|
|
2
|
Gran JT: The epidemiology of chronic
generalized musculoskeletal pain. Best Pract Res Clin Rheumatol.
17:547–561. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Russell IJ and Larson AA:
Neurophysiopathogenesis of fibromyalgia syndrome: A unified
hypothesis. Rheum Dis Clin North Am. 35:421–435. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Russell IJ, Orr MD, Littman B, Vipraio GA,
Alboukrek B, Michalek JE, Lopez Y and MacKillip F: Elevated
cerebrospinal levels of substance P in patients fibromyalgia
syndrome. Arthritis Rheum. 37:1593–1601. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Giovengo SL, Russell IJ and Larson AA:
Increased concentrations of nerve growth factor in cerebrospinal
fluid of patients with fibromyalgia. J Rheumatol. 26:1564–1569.
1999.PubMed/NCBI
|
|
6
|
Ozgocmen S, Ozyurt H, Sogut S and Akyol H:
Current concepts in the pathophysiology of fibromyalgia: The
potential role of oxidative stress and nitric oxide. Rheumatol Int.
26:585–597. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Maes M, Libbrecht I, Van Hunsel F, Lin AH,
De Clerck L, Stevens W, Kenis G, de Jongh R, Bosmans E and Neels H:
The immune-inflammatory pathophysiology of fibromyalgia: Increased
serum soluble gp130, the common signal transducer protein of
various neurothrophic cytokines. Psychoneuroendocrinology.
24:371–383. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bondy B, Spaeth M, Offenbaecher M,
Glatzeder K, Stratz T, Schwarz M, de Jonge S, Krüger M, Engel RR,
Färber L, et al: The T102C polymorphism of the 5-HT2A-receptor gene
in fibromyalgia. Neurobiol Dis. 6:433–439. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Vargas-Alarcón G, Fragoso JM, Cruz-Robles
D, Vargas A, Vargas A, Lao-Villadóniga JI, García-Fructuoso F,
Ramos-Kuri M, Hernández F, Springall R, et al:
Catechol-O-methyltransferase gene haplotypes in Mexican and Spanish
patients with fibromyalgia. Arthritis Res Ther. 9:R1102007.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Buskila D, Cohen H, Neumann L and Ebstein
RP: An association between fibromyalgia and the dopamine D4
receptor exon III repeat polymorphism and relationship to novelty
seeking personality traits. Mol Psychiatr. 9:730–741. 2004.
View Article : Google Scholar
|
|
11
|
Vane JR, Anggård EE and Botting RM:
Regulatory functions of the vascular endothelium. N Engl J Med.
323:27–36. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Schiffrin EL and Thibault G: Plasma
endothelin in human essential hypertension. Am J Hypertens.
4:303–308. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Arinami T, Ishikawa M, Inoue A, Yanagisawa
M, Masaki T, Yoshida MC and Hamaguchi H: Chromosomal assignments of
the human endothelin family genes: The endothelin-1 gene (EDN1) to
6p23-p24, the endothelin-2 gene (EDN2) to 1p34 and the endothelin-3
gene (EDN3) to 20q13.2-q13.3. Am J Hum Genet. 48:990–996.
1991.PubMed/NCBI
|
|
14
|
Pache M, Schwarz HA, Kaiser HJ, Wüest P,
Klöti M, Dubler B and Flammer J: Elevated plasma endothelin-1
levels and vascular dysregulation in patients with rheumatoid
arthritis. Med Sci Monit. 8:CR616–CR619. 2002.PubMed/NCBI
|
|
15
|
Kuryliszyn-Moskal A, Klimiuk PA,
Sierakowski S and Ciolkiewicz M: A study on vascular endothelial
growth factor and endothelin-1 in patients with extra-articular
involvement of rheumatoid arthritis. Clin Rheumatol. 25:314–319.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
La Montagna G, Cacciapuoti F, Buono R,
Manzella D, Mennillo GA, Arciello A, Valentini G and Paolisso G:
Insulin resistance is an independent risk factor for
atherosclerosis in rheumatoid arthritis. Diab Vasc Dis Res.
4:130–135. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Stavropoulos-Kalinoglou A, Metsios GS,
Koutedakis Y, Nevill AM, Douglas KM, Jamurtas A, van Zanten JJ,
Labib M and Kitas GD: Redefining overweight and obesity in
rheumatoid arthritis patients. Ann Rheum Dis. 66:1316–1321. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Panoulas VF, Douglas KM, Smith JP, Taffé
P, Stavropoulos-Kalinoglous A, Toms TE, Elisaf MS, Nightingale P
and Kitas GD: Polymorphisms of the endothelin-1 gene associate with
hypertension in patients with rheumatoid arthritis. Endothelium.
15:203–212. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wolfe F, Smythe HA, Yunus MB, Bennett RM,
Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M,
Clark P, et al: The American College of rheumatology 1990 criteria
for the classification of fibromyalgia. Report of the multicenter
criteria committee. Arthritis Rheum. 33:160–170. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Okifuji A, Turk DC, Sinclair JD, Starz TW
and Marcus DA: A standardized manual tender point survey. I.
Development and determination of a threshold point for the
identification of positive tender points in fibromyalgia syndrome.
J Rheumatol. 24:377–383. 1997.PubMed/NCBI
|
|
21
|
Kim YA, Lee SS and Park K: Validation of a
Korean version of the fibromyalgia impact questionnaire. J Korean
Med Sci. 17:220–224. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mendoza TR, Wang XS, Cleeland CS,
Morrissey M, Johnson BA, Wendt JK and Huber SL: The rapid
assessment of fatigue severity in cancer patients: Use of the brief
fatigue inventory. Cancer. 85:1186–1196. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Richter P, Werner J, Heerlein A, Kraus A
and Sauer H: On the validity of the beck depression inventory. A
review. Psychopathology. 31:160–168. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ware JE Jr and Sherbourne CD: The MOS
36-item short-form health survey (SF-36). I. Conceptual framework
and item selection. Med Care. 30:473–483. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kim JT and Shin DG: A standardization
study of State-Trait Anxiety Inventory in Korea. New Med J.
21:1223–1229. 1978.
|
|
26
|
Lee H, Kim HK, Won H, Im J, Kwon JT and
Kim HJ: Genetic relationship between an endothelin 1 gene
polymorphism and lead-related high blood pressure. Mol Cell
Toxicol. 12:111–116. 2016. View Article : Google Scholar
|
|
27
|
Bauer V and Sotníková R: Nitric oxide-the
endothelium-derived relaxing factor and its role in endothelial
functions. Gen Physiol Biophys. 29:319–340. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Goodwin AT, Smolenski RT, Gray CC,
Jayakumar J, Amrani M and Yacoub MH: Role of endogenous endothelin
on coronary reflow after cardioplegic arrest. J Thorac Cardiovasc
Surg. 122:1167–1173. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Forbes JM, Jandeleit-Dahm K, Allen TJ,
Hewitson TD, Becker GJ and Jones CL: Endothelin and endothelin A/B
receptors are increased after ischaemic acute renal failure. Exp
Nephrol. 9:309–316. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Flammer J, Pache M and Resink T:
Vasospasm, its role in the pathogenesis of diseases with particular
reference to the eye. Prog Retin Eye Res. 20:319–349. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Pache M, Ochs J, Genth E, Mierau R, Kube T
and Flammer J: Increased plasma endothelin-1 levels in fibromyalgia
syndrome. Rheumatology (Oxford). 42:493–494. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kim SK, Kim KS, Lee YS, Park SH and Choe
JY: Arterial stiffness and proinflammatory cytokines in
fibromyalgia syndrome. Clin Exp Rheumatol. 28 6 Suppl 63:S71–S77.
2010.PubMed/NCBI
|
|
33
|
Bennett RM, Clark SR, Campbell SM, Ingram
SB, Burckhardt CS, Nelson DL and Porter JM: Symptoms of Raynaud's
syndrome in patients with fibromyalgia. A study utilizing the
Nielsen test, digital photoplethysmography and measurements of
platelet a2-adrenergic receptors. Arthritis Rheum. 34:264–269.
1991. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lapossy E, Gasser P, Hrycaj P, Dubler B,
Samborski W and Muller W: Cold-induced vasospasm in patients with
fibromyalgia and chronic low back pain in comparison to healthy
subjects. Clin Rheumatol. 13:442–445. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Nelson JB, Chan-Tack K, Hedican SP,
Magnuson SR, Opgenorth TJ, Bova GS and Simons JW: Endothelin-1
production and decreased endothelin B receptor expression in
advanced prostate cancer. Cancer Res. 56:663–668. 1996.PubMed/NCBI
|
|
36
|
Ahn GY, Butt KI, Jindo T, Yaguchi H,
Tsuboi R and Ogawa H: The expression of endothelin-1 and its
binding sites in mouse skin increased after ultraviolet B
irradiation or local injection of tumor necrosis factor alpha. J
Dermatol. 25:78–84. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Druml W, Steltzer H, Waldhäusl W, Lenz K,
Hammerle A, Vierhapper H, Gasic S and Wagner OF: Endothelin-1 in
adult respiratory distress syndrome. Am Rev Respir Dis.
148:1169–1173. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Voerman HJ, Stehouwer CD, van Kamp GJ, van
Schijndel RJ Strack, Groeneveld AB and Thijs LG: Plasma endothelin
levels are increased during septic shock. Crit Care Med.
20:1097–1101. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kidd BL and Urban LA: Mechanisms of
inflammatory pain. Br J Anaesth. 87:3–11. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Schaible HG, Ebersberger A and Von Banchet
GS: Mechanisms of pain in arthritis. Ann NY Acad Sci. 966:343–354.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Rae GA and Henriques MG: Endothelins in
inflammationPro-Inflammatory and Anti-Inflammatory Peptides. Said
S: Marcel Dekker; New York, NY: pp. 163–202. 1998
|
|
42
|
Miyasaka N, Hirata Y, Ando K, Sato K,
Morita H, Shichiri M, Kanno K, Tomita K and Marumo F: Increased
production of endothelin-1 in patients with inflammatory
arthritides. Arthritis Rheum. 35:397–400. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Savoia C and Schiffrin EL: Inhibition of
the renin angiotensin system: Implications for the endothelium.
Curr Diab Rep. 6:274–278. 2016. View Article : Google Scholar
|
|
44
|
Libby P: Current concepts of the
pathogenesis of the acute coronary syndromes. Circulation.
104:365–372. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Blake JG and Ridker PM: Novel clinical
markers of vascular wall inflammation. Circ Res. 89:763–771. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Sesso HD, Buring JE, Rifai N, Blake GJ,
Gaziano JM and Ridker PM: C-reactive protein and the risk of
developing hypertension. JAMA. 290:2945–2951. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Preston RA, Ledford M, Materson BJ,
Baltodano NM, Memon A and Alonso A: Effects of severe, uncontrolled
hypertension on endothelial activation: soluble vascular cell
adhesion molecule-1, soluble intercellular adhesion molecule-1 and
von Willebrand factor. J Hypertens. 20:871–877. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Blake GJ, Rifai N, Buring JE and Ridker
PM: Blood pressure, C-reactive protein, and risk of future
cardiovascular events. Circulation. 108:2993–2999. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Thorand B, Löwel H, Schneider A, Kolb H,
Meisinger C, Fröhlich M and Koenig W: C-reactive protein as a
predictor for incident diabetes mellitus among middle-aged men:
Results from the MONICA Augsburg cohort study, 1984–1998. Arch
Intern Med. 163:93–99. 2003. View Article : Google Scholar : PubMed/NCBI
|
